Simultaneous PD-1/VEGF/CTLA-4 blockade aims to compress multi-drug regimens into a single infusion, raising questions about ...
In the ICARUS-BREAST 01 study, more than half of patients with metastatic breast cancer saw their disease decrease or ...
Tubulis, a company spun off from the Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP) and LMU Munich in 2019, has announced positive early clinical data from the Phase I/IIa NAPISTAR1-01 ...
Astellas Pharma (ALPMY) and Pfizer (PFE) announced positive results from the Phase 3 EV-303 clinical trial for PADCEV, a Nectin-4 directed ...